Goodpasture's Syndrome: Understanding Kidney Autoimmune Disease
Goodpasture's syndrome (anti-GBM disease) is a rare autoimmune disorder characterized by autoantibodies targeting the glomerular basement membrane (GBM) in kidneys and alveolar basement membrane in lungs.
Pathophysiology
- Autoantibodies: Primarily IgG against α3 chain of type IV collagen (Goodpasture antigen)
- Targets: Renal glomeruli → rapidly progressive glomerulonephritis; Pulmonary alveoli → alveolar hemorrhage
- Trigger: Often unknown; possible viral infections, hydrocarbon exposure, smoking, genetic susceptibility (HLA-DR15)
Clinical Presentation
- Hemoptysis (coughing blood) — pulmonary involvement
- Hematuria, proteinuria, rapidly rising creatinine — renal involvement
- Fatigue, anemia, dyspnea
- May present as renal-limited or pulmonary-limited
Diagnosis
- Anti-GBM antibody test (serum)
- Kidney biopsy: linear IgG deposition on GBM (pathognomonic)
- ANCA may be positive in 20-30% (double-positive)
Treatment
- Plasmapheresis (removes antibodies)
- Immunosuppression: Cyclophosphamide + corticosteroids
- Supportive: dialysis if renal failure, respiratory support if hemorrhage
Prognosis
Early treatment improves renal survival. Delayed diagnosis often leads to ESRD requiring transplant. Relapse is rare after treatment completion.
Kidney Disease - Related Articles
- Kidney Cancer Treatment Options: Surgery, Ablation, Systemic Therapy, and Surveillance
- Kidney Bruise Treatment & Recovery: Symptoms, Causes & Healing
- Renal vs. Prerenal Failure: Understanding the Differences
- Nephrons: Understanding the Functional Units of the Kidney
- Lithotripsy (ESWL) for Kidney Stones: Size-Based Success Rates
- OTC Cold Medications & Kidney Health: What You Need to Know
- Understanding Kidney Dialysis: Treatment, Types & Benefits
